STENYSESEC EDGAREDGAR

STERIS plc

Orthopedic, Prosthetic & Surgical Appliances & Supplies·DUBLIN, L2·FY end 03/31·CIK 1757898
CEO Pay Ratio
151:1
Daniel A. Carestio
CEO Total Comp
$10.7M
Daniel A. Carestio
Median Employee
$70,915
Revenue
$5.5B
FY 2025
Net Income
$614.6M
FY 2025
Free Cash Flow
$778.0M
FY 2025
Net Margin
11.3%
Insider Net (180d)
$0
0 buys / 0 sales

CEO Pay Accountability

CEO comp as % of net income
1.74%
For every $1,000 of profit, $17.40 flows to the CEO.
CEO comp as % of buybacks
5.06%
CEO comp equals 50.6‰ of cash returned to shareholders via buybacks.

Financials

5-year history · USD
MetricFY 2025FY 2024FY 2023FY 2022FY 2021Trend
Revenue$5.5B$1.4B$5.0B$1.2B$873.5M
Gross Profit$2.4B$582.9M$2.2B$571.6M$379.8M
Operating Income$866.6M$836.1M$268.2M$425.6M$548.4M
Net Income$614.6M-$1.4M$107.0M$52.3M$87.4M
Operating CF$1.1B$973.3M$756.9M$684.8M$689.6M
Capex$370.1M$360.3M$362.0M$287.6M$239.3M
Free Cash Flow$778.0M$612.9M$395.0M$397.2M$450.4M
Buybacks$211.3M$11.8M$308.6M$55.8M$14.6M
Dividends$219.9M$200.6M$183.5M$163.2M$133.8M
Gross Margin44.0%41.1%43.6%47.2%43.5%
Operating Margin15.9%58.9%5.4%35.2%62.8%
Net Margin11.3%-0.1%2.2%4.3%10.0%
FCF Margin14.3%43.2%8.0%32.8%51.6%
R&D / Revenue2.0%7.3%2.0%7.3%7.6%
Effective Tax23.2%19.6%32.8%22.8%
Debt / Equity0.580.990.990.900.85
Buybacks / FCF27.2%1.9%78.1%14.0%3.3%

Named Executive Officers

FY 2025
ExecutiveSalaryStockOptionsBonus / Inc.OtherTotal
Daniel A. Carestio · CEO
$10.7M